The Cannigma

JUNE 30, 2021

In 2014 the state legalized recreational cannabis and as of 2021 has one of the highest concentrations of legal cannabis retail stores in the country, though the total number of medical cannabis patients (22,566) is relatively low compared to the state’s population. Cancer 839 7.8%. PTSD 12,546 20.6% Severe arthritis 8,290 13.6%

Chronic Pain 137

Chronic Pain Marijuana Conditions Patients 137

Cannabis Law Report

JUNE 7, 2021

Since 2014, when sales began in Colorado and Washington, legalization policies have provided states a new revenue stream to bolster budgets and fund important services and programs. Washington’s voters also approved an adult-use measure in November 2012, and its first stores opened in July 2014. Colorado (pop. 46,104,922. 104,759,961.

Marijuana 91

Marijuana Retail Collective Programs 91

Puff Puff Post

SEPTEMBER 16, 2019

16, 2019 /CNW/ – Québec doctors have a new tool at their disposal for learning about medical cannabis and its viability as a treatment option for their patients. “It is our duty as physicians to understand the available treatment options for our patients, and medical cannabis treatments have emerged as an important clinical tool.

Programs 108

Programs Research and Development Education Treatment 108

Cannabis Chronicles

JANUARY 2, 2019

It’s a non-psychoactive compound found in marijuana and hemp plants and used for treatment of certain medical problems. He started the company in 2014 with two friends. It’s not just the U.S. It’s spreading,” said Ben Curren, CEO of Green Bits, a San Jose, Calif., company that develops software for marijuana retailers and businesses.

Legalization 100

Legalization Research and Development Recreational Data 100

Cannabis Law Report

APRIL 13, 2022

The Center Square) – Marijuana sales in Colorado continued a downward trend in February totaling $145 million, according to the state’s latest market data. billion since legalization in 2014. . The monthly reports are now replaced with two reports that have data from every month since 2014.

Marijuana 52

Marijuana Data Retail Collective 52

Cannabis Law Report

AUGUST 10, 2021

The global chronic pain treatment market is predicted to progress at a CAGR of 6.5% It is an honour and privilege to be in the position to use novel psychedelic treatments to solve the complex puzzle that is chronic pain. 1 Global Chronic Pain Treatment Market Analysis and Growth Forecast Report 2020 – 2030. 2014; 7: 115-124.

Chronic Pain 105

Chronic Pain Clinical Trials Research and Development Events 105

Sensi Seeds

DECEMBER 10, 2018

They evaluate data, which is now available thanks to the efforts of the cannabis policy reform movement, and try to provide answers, especially to those who need them most, namely, medical patients. Consequently, they sorted the publications into three main groups: psychiatry, cancer treatment, and neurology.

Medicine 81

Medicine Research and Development Data Policy 81

Greencamp

APRIL 23, 2019

For patients who don’t respond well to conventional MS methods, cannabis treatment seems like a very reasonable choice. Since so little is known about the exact cause of this condition, and a cure hasn’t been found yet, treatment options are limited but they do exist. What is multiple sclerosis? three days.

Research and Development 94

Research and Development Strains Patients Treatment 94

CannaMD

FEBRUARY 12, 2020

As Vice President under Barack Obama, Biden’s position on marijuana remained unchanged, even after Obama went on record in 2014 saying he had used marijuana in his youth, and declared that, while he considered it a bad habit it like cigarettes: “I don’t think it is more dangerous than alcohol.”. The punishment should fit the crime.

Marijuana 109

Marijuana Policy Decriminalization Legalization 109

CannaMD

FEBRUARY 22, 2021

Yet, data suggests otherwise. And according to that data, there appears to be little to no correlation between cannabis legalization and underage marijuana use on a state-by-state basis. of eleventh graders reported having used the drug within the past month, according to data collected from 2013-2015. California. Washington.

Recreational 59

Recreational Marijuana Data Consumption 59

Cannabis Law Report

OCTOBER 29, 2021

Using data from the National Survey on Drug Use and Health (2005–2014), the present study examined the associations between lifetime classic psychedelic use and two types of cardiometabolic disease: heart disease and diabetes.

Research and Development 52

Research and Development Treatment Data Conditions 52

Cannabis Chronicles

JULY 2, 2019

The ban has been in place since 2014, two years after Washington voters approved a ballot initiative legalizing the drug for recreational use. I’m trying to let the data drive my decision on where we go with this,” said Olson, who noted that she voted against legalization. Quiring and Councilor Gary Medvigy voted against it.

Marijuana 100

Marijuana Retail Recreational Business 100

Cannabis Law Report

FEBRUARY 25, 2022

Medical cannabis producers in the state had requested tax refunds in 2014 and in 2018 but the state Taxation and Revenue Department had denied those claims. New Mexico launched its medical cannabis program in 2007 and, as of January, the program had more than 130,340 enrolled patients, according to state Department of Health data.

Programs 52

Programs Collective Data Patients 52

Cannabis Law Report

MARCH 11, 2022

It became necessary to establish a legal framework to manage cannabis waste, in particular, its classification, transportation and treatment. Under a basic principle of the General Waste Management Framework (Regime Geral de Gestão de Resíduos – “RGGR”), the waste producer is responsible for ensuring the treatment of waste.

Medicine 52

Medicine Treatment Packaging Digestion 52

The Cannigma

MAY 16, 2025

Their efforts resulted in legal protections for patients and providers at the state level, but spurred federal attacks that continued for 28 years until the passage of the Rohrabacher-Farr Amendment in 2014. and years of data proving the positive impacts that medical cannabis has on healthcare systems.

Policy 92

Policy Access Advocacy Patients 92

Canna Care Docs

DECEMBER 16, 2020

It would feel like an out-of-body experience, except for one fact: your body is constantly reminding you of those symptoms you’ve been suffering from all this time, putting treatment on the back burner while you deal with life as we know it. Research is ongoing, but the existing data and anecdotal reports show potential.

Chronic Pain 52

Chronic Pain Marijuana Clinical Trials Epilepsy 52

WeedAdvisor

APRIL 1, 2019

In 2014, researchers examined existing evidence, publishing a review concluding that CBD can be effective at treating osteoarthritis in animals. A study published in 2014 found possible antidepressant and anti-anxiety effects in animal models. Sadly, a dog cannot tell us that he or she is nauseous from the treatment.

Pets 49

Pets Oil CBD Research and Development 49

The Joint Blog

DECEMBER 18, 2019

– Colorado county-level data show OTC sleep aid sales decline with recreational cannabis access, especially for diphenhydramine and doxylamine. . Highlights of the study include: – Nearly 50% of US populations suffers from sleep disturbances; if cannabis can treat insomnia, this is clinically relevant. .

Sleep 49

Sleep Legalization Marijuana Recreational 49

Cannabis Law Report

NOVEMBER 12, 2021

This announcement contains inside information for the purposes of Article 7 of EU Regulation 596/2014 (which forms part of domestic UK law pursuant to the European Union (Withdrawal) Act 2018). For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

Cannabinoids 98

Cannabinoids Clinical Trials Research and Development Pharmaceutical 98

MMJ Recs

FEBRUARY 8, 2021

Medical marijuana in New York has been legal since legislation for the Compassionate Care Act was passed in June of 2014. Medicaid, or other health insurances, do not cover the use of medical marijuana for any chronic illness, and thus, those looking to supplement their treatment with cannabis will have to pay out of pocket.

Legalization 52

Legalization Edibles Patients Treatment 52

Cannabis Law Report

JANUARY 9, 2022

Since 2014 when sales began in Colorado and Washington, legalization policies have provided states a new revenue stream to bolster budgets and fund important services and programs. Washington’s voters also approved an adult-use measure in November 2012, and its first stores opened in July 2014. Here’s what they say. 46,104,922.

Collective 52

Collective Policy Retail Programs 52

Cannabis Law Report

APRIL 5, 2019

For decades, analysts interested in the tax revenue potential of legalizing cannabis had to use unreliable survey data and speculation regarding how a legal market might operate. Alaska and Oregon do not levy statewide general sales taxes and Massachusetts is not yet reporting data. But this is changing.

Collective 45

Collective Data Recreational Cannabis 45

TheAnswerPage

DECEMBER 29, 2021

This observation, along with more recent data (3,4) showing that the insula may control processes that moderate or inhibit addictive behavior, suggested the existence of a neurochemical, sensitive to brain injury, that might counteract nicotine reward and dependence. Academic Press, Elsevier, Amsterdam 2014. Naqvi NH, Rudrauf, D.,

Data 52

Data Treatment Medicine 52

Cannabis Law Report

SEPTEMBER 26, 2019

SANTA FE – Tax dollars generated by legalizing recreational cannabis use in New Mexico could be used to pay for law enforcement training, mental health programs, drug addiction treatment and more, under recommendations being crafted by a state task force.

Programs 40

Programs Collective Legislation Recreational 40

The Cannigma

MAY 9, 2021

A 2018 study by Frontier Data found that combined with illegal cultivation, the total electricity consumption by cannabis production climbs to 4.1 Since 2014, the Cannabis Research Center has documented the locations of over 10,000 permitted and unpermitted cultivation sites in California. pharmaceutical industry energy expenditure.

Agriculture 145

Agriculture Cultivation Wellness and Beauty Consumption 145

Cannabis Law Report

JUNE 1, 2021

During his career, Dr. McLin has supported the launch of six products at start-up and mid-size pharmaceutical companies, where he has identified innovative, data-driven opportunities to engage patients, prescribers, and payers. Company remains on track for potential approval of Vicineum™ in the US in August 2021. CAMBRIDGE, Mass.–(BUSINESS

Research and Development 51

Research and Development Treatment Pharmaceutical Patients 51

Cannabis Law Report

APRIL 12, 2019

Founded in 2014, Canadians for Fair Access to Medical Marijuana (CFAMM) (Canadiens pour l’accès équitable à la marijuana médicale (CAEMM)) is a federal non-partisan, non-profit, patient-run organisation dedicated to protecting and improving the rights of medical cannabis patients. Patient advocacy is alive and well in Canada.

Access 45

Access Patients Marijuana Medicine 45

Puff Puff Post

SEPTEMBER 16, 2019

16, 2019 /CNW/ – Québec doctors have a new tool at their disposal for learning about medical cannabis and its viability as a treatment option for their patients. “It is our duty as physicians to understand the available treatment options for our patients, and medical cannabis treatments have emerged as an important clinical tool.

Programs 40

Programs Research and Development Education Treatment 40

Cannabis Law Report

JANUARY 10, 2022

For instance, an ongoing clinical trial, initiated in April 2021, analyzing the utilization of products, such as THCV, CBDV, and CBD-rich hemp oil, on the treatment of androgenetic Alopecia. List To Data Sources. Opportunity Analysis (2014-2020-2028). Such instances are projected to fuel market growth over the forecast period.

Cannabinoids 40

Cannabinoids Clinical Trials Research and Development Supply Chain 40

Cannabis Law Report

APRIL 8, 2022

This year, we are completing the second Phase 3 clinical trial of MDMA-assisted therapy for PTSD , the final stage prior to requesting FDA approval for a new prescription treatment to help heal trauma. For over three decades, we’ve been working to achieve mass mental health throughout the United States, Canada, and Europe.

Clinical Trials 52

Clinical Trials Therapy Research and Development DEA 52

Veriheal

MAY 14, 2021

Additionally, data suggests that “m easuring the thickness of human cerebral cortex could provide powerful tools for diagnosing and studying a variety of neurodegenerative and psychiatric disorders” which demonstrates the importance of understanding what impacts cortical thickness as well as its significance. .

Research and Development 52

Research and Development Consumption Cannabis Data 52

Cannabis Law Report

MAY 17, 2019

Agricultural Act of 2014, 7 U.S. A fast-growing, sustainable, and inexpensively produced plant, “Industrial Hemp” is a variety of Cannabis sativa L. containing less than 0.3% plant chemical delta-9 tetrahydrocannabinol (“THC”). Code §5940.

Food 10

Food DEA Hemp CBD 10

Cannabis Law Report

JULY 30, 2019

. “Today, Americans for Safe Access (ASA), the leading advocacy organization dedicated to ensuring safe and legal access to cannabis (marijuana) for therapeutic use and research, and Aurelius Data , Inc.(AD), Green Entrepreneur- Move Aside, CBD: New Data Finds THC Is the Real Medicine in Medical Marijuana. . Contact Heather.

Marijuana 45

Marijuana Patients Research and Development Programs 45

Cannabis Law Report

NOVEMBER 24, 2021

At the same time, the outlook on cannabis research data is largely positive. It was also used as a topical treatment for haemorrhoids, ear infection, and wounds (Aldrich 1997 ; Touw 1981 ). The latter remains a dangerous drug and is considered higher risk for treatment than CBD (TGA 2019 ). Data collection.

Research and Development 52

Research and Development Medicine Access Media 52

Cannabis Law Report

AUGUST 24, 2019

Alaska voters legalized recreational marijuana in 2014. Physicians : Approximately 2,300 Florida Medics who recommend cannabis as treatment for a wide variety of conditions and symptoms. Marijuana-related businesses cannot continue the program beyond a pilot phase without the liability coverage, said Credit Union 1 CEO James Wileman.

Banking 49

Banking Marijuana Media Patients 49

SpeedWeed

DECEMBER 28, 2018

In August, Constellation Brands (brewers of Corona beer) spent $4 billion to massively up their stake in Canopy Growth, which in 2014 became the first publicly traded cannabis company in North America, and now lists on both the New York Stock Exchange and the Toronto Stock Exchange. RELATED STORY.

Pharmaceutical 40

Pharmaceutical Research and Development Legalization CBD 40

Greenspoon Marder Cannabis Law Group Blog

JUNE 25, 2021

Moreover, as a result of the enactment of what is commonly referred to as the Tax Cuts and Jobs Act of 2017 (the “Act”), the treatment of income derived by foreign affiliates of U.S. cannabis companies and other entities, according to data from Viridian Capital Advisers.” Instead, only the U.S. Territorial Tax Regime Introduced.

Business 72

Business Cannabis Seed-To-Sale Law 72